SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Y K Hamied buys 5.22% additional stake in Cipla

03 Feb 2016 Evaluate

In a move aimed at realignment of family shareholding, Cipla patriarch Y K Hamied, Non-Executive Chairman of the company has acquired 5.22% additional stake in the company from his wife Farida Hamied. Following the acquisition, his total holding in the drug firm increased to 20.76% from earlier stake of 15.54%.

The transfer of shares is being done by way of gift. The development comes at a time when the Mumbai-based drug maker is in the midst of a transition in leadership.

Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 150 countries. Its portfolio includes 1500 plus products across therapeutic categories with one quality standard globally.

Cipla Share Price

1237.60 -0.70 (-0.06%)
20-Apr-2026 10:28 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1670.25
Dr. Reddys Lab 1235.65
Cipla 1237.60
Zydus Lifesciences 940.00
Lupin 2327.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×